SCHEMBL7994994

SCHEMBL7994994

CCOC(=O)CCCOc1ccncc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 2/20 0.54
CYSLTR1 Q9Y271 2/20 0.54
BRD4 O60885 1/20 0.51
FAAH O00519 1/20 0.50
LTA4H P09960 2/20 0.49
LMNA P02545 2/20 0.49
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
P2RY12 Q9H244 1/20 0.48
HRH2 P25021 1/20 0.48
HRH1 P35367 1/20 0.48
MAPT P10636 1/20 0.48
TBXAS1 P24557 1/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
NPC1 O15118 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24936702 0.92 TDP1 (0.51) CYSLTR2CYSLTR1LTA4HLMNAHRH2
SCHEMBL9127586 0.89 CYSLTR2 (0.51) CYSLTR2CYSLTR1BRD4FAAHLTA4H
SCHEMBL9127593 0.89 CYSLTR2 (0.51) CYSLTR2CYSLTR1BRD4FAAHLTA4H
SCHEMBL7334450 0.84 HRH3 (0.57) CYSLTR2CYSLTR1FAAHHRH2HRH1
SCHEMBL6937314 0.83 MEN1 (0.62) CYSLTR2CYSLTR1BRD4FAAHLTA4H
SCHEMBL767042 0.83 TDP1 (0.62) CYSLTR2CYSLTR1FAAHLTA4HLMNA
SCHEMBL7398657 0.82 LMNA (0.50) CYSLTR2CYSLTR1LTA4HLMNAMAPT
SCHEMBL8981963 0.82 BRD4 (0.56) CYSLTR2CYSLTR1BRD4LTA4HHRH2
SCHEMBL3466988 0.82 CYSLTR2 (0.59) CYSLTR2CYSLTR1BRD4FAAHLTA4H
SCHEMBL30178403 0.82 TBXAS1 (0.56) CYSLTR2CYSLTR1FAAHLMNATBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294549-B1 COMPOUNDS USEFUL FOR INHIBITING RESTENOSIS, ANGIOGENESIS, ATHEROSCLEROSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, INFLAMMATION OR TUMOR GROWTH. MERCK & CO., INC. 2001-09-25 US disclosed
US-5952306-A INHIBITING THE BINDING OF FIBRINOGEN TO BLOOD PLATELETS AND INHIBITING THE AGGREGATION OF BLOOD PLATELETS; INHIBITING OSTEOCLAST CELLULAR ADHESION TO BONE SURFACES MERCK & CO., INC. (US) 1999-09-14 US disclosed